US Patent 11174226 Azetidinimines as carbapenemases inhibitors

Patent 11174226 was granted and assigned to National Center for Scientific Research on November, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

National Center for Scientific Research

Current Assignee

National Center for Scientific Research

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

111742260

Patent Inventor Names

Thierry Naas0

Corinne Minard0

Kevin Cariou0

Robert Dodd0

Bogdan-Iuliu Iorga0

Date of Patent

November 16, 2021

Patent Application Number

157590840

Date Filed

September 7, 2016

Patent Primary Examiner

‌

Alicia L Otton

Patent abstract

The present application relates to novel azetidinimine of formula (I). Wherein R1-R6 are as defined in claim 1. The azetidinimine of the invention are useful as antibiotics and as inhibitors of a carbapenemases. The present invention thus further relates to their use in antibiotic therapies and their methods of synthesis.